Antibodies against Superantigenic Exotoxins Produced by Staphylococcus aureus in Sera from Mothers and Their Infants' Cord Blood

ABSTRACT

A novel neonatal disease and puerperal toxic shock syndrome (TSS) induced by a superantigen, TSS toxin-1 (TSST-1), has spread throughout Japan. It is important to investigate serum titers against exotoxins in new mothers and in their infants' cord blood. We investigated antitoxin antibodies against TSST-1, staphylococcal enterotoxin (SE) A (SEA), SEB, and SEC, including immunoglobulin G (IgG) subclass specificity by enzyme-linked immunosorbent assay, in sera from 221 mothers and 97 cord blood samples. The rate of mothers with negative anti-TSST-1 antibody titer was high (more than 40%). Although antitoxin antibody titers in the sera of cord blood were well correlated with those in the sera of the mothers for every toxin, the tendencies of antibody transmission differed between toxins. Anti-TSST-1 antibody consisted mainly of IgG1 and IgG4 subclasses. Anti-TSST-1 IgG1- and IgG4-specific antibody titers in cord blood were well correlated with those in the sera of the mothers. The low frequency of pregnant women with positive anti-TSST-1 antibody titers could be one reason for the spread of TSS in Japan. Neonates whose mothers have positive IgG titers against TSST-1 should be protected because the antibody is composed of the subclasses transferred well through the placenta.

KEYWORDS

Superantigen - toxic shock syndrome toxin-1 - antibodies - cord blood - enzyme-linked immunosorbent assay (ELISA)

REFERENCES

• 1 Todd J, Fishaut M, Kapral F, Welch T. Toxic shock syndrome associated with phage group staphylococci.  Lancet. 1978;  2 1116-1118
• 2 Kotzin B, Leung D YM, Kappler J, Marrack P. Superantigens and their potential role in human disease.  Adv Immunol. 1993;  54 99-166
• 3 Uchiyama T, Yan X-J, Imanishi K, Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases.  Microbiol Immunol. 1994;  38 245-256
• 4 Shands K N, Schmid G P, Dan B B et al.. Toxic shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and the clinical features in 52 cases.  N Engl J Med. 1980;  303 1436-1442
• 5 Takahashi N, Nishida H. A new exanthematous disease with thrombocytopenia in newborn infants.  Arch Dis Child. 1997;  77 F79
• 6 Takahashi N, Nishida H, Kato H et al.. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.  Lancet. 1998;  351 1614-1619
• 7 Takahashi N. Neonatal toxic shock syndrome-like exanthematous disease (NTED).  Pediatr Int. 2003;  45 233-237
• 8 Kikuchi K, Takahashi N, Piao C, Totsuka K, Nishida H, Uchiyama T. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards.  J Clin Microbiol. 2003;  41 3001-3006
• 9 Fujiwara Y, Endo S. A case of toxic shock syndrome secondary to mastitis caused by methicillin-resistant Staphylococcus aureus .  J Jpn Assoc Infect Dis. 2001;  75 898-903
• 10 Christensson B, Hedstrom S A. Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls.  Acta Path Microbiol Immunol Scand. 1985;  93 87-90
• 11 Takahashi N, Kato H, Imanishi K et al.. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.  J Clin Invest. 2000;  106 1409-1415
• 12 Bergdoll M S. Staphylococcal toxin antibody titers in humans.  Clin Immunol Newsl. 1987;  8 149-152
• 13 Loch E-G, Crass B A, Bergdoll M S. Staphylococcus aureus-toxic shock syndrome toxin-1 antibody titers in serum of German women.  Arch Gynecol. 1986;  237 229-233
• 14 Miwa K, Fukuyama M, Sakai R et al.. Sensitive enzyme-linked immunosorbent assays for detection of bacterial superantigens and antibodies against them in human plasma.  Microbiol Immunol. 2000;  44 519-523
• 15 Matsubara K, Fukaya T, Miwa K et al.. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogens in Kawasaki disease.  Clin Exp Immunol. 2006;  143 427-434
• 16 Mahieu L M, Holm S E, Goossens H J, Van Acker K J. Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins.  J Pediatr. 1995;  127 987-989
• 17 Christensson B, Johansson P JH, Oxelius V-A. Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.  Clin Exp Immunol. 1986;  66 443-449
• 18 Wilson C B. Developmental immunology and role of host defenses in neonatal susceptibility. In: Remington JS, Klein JO Infectious Diseases of the Fetus and Newborn Infant. 3rd ed. Philadelphia; W.B. Saunders 1990: 17-67
• 19 Bavari S, Dyas B, Ulrich R. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.  J Infect Dis. 1996;  174 338-345
• 20 van der Mee-Marquet N, Lina G, Quentin R et al.. Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists.  J Clin Microbiol. 2003;  41 4883-4884